This is the sixth symposium in a series of symposia on immunology organized by IMMUNO covering this time tumor immunology. This volume deals with T cell recognition and CD95-associating signaling, clinical investigations: cells, costimulatory signals and therapeutic approaches: cytokines and vaccines.

T Cell Recognition and CD95-Associating Signalling

Characterization of Antigens Recognized by T Cells on Human Tumors
Shared and Individual CTL-Defined Antigens on Human Melanoma Cells
Deficiencies of the MHC Class I Antigen Processing and Presentation Machinery in Tumor Cells
The Use of HLA Transgenic Mice in Identifying and Targeting Human Tumor Cell Antigens
CD95-Associating Signaling Molecules
Clinical Investigations: Cells, Costimulatory Signals
Adoptive Immunotherapy in Chimeras
Towards the Development of Immunogenic Colon Cancer Cells for Immunotherapy
Gene-Modified Dendritic Cells as Vaccines for the Induction of Anti-Tumor Immunity
Potent Presentation of Soluble Protein Antigens by In Vitro-Generated Dendritic Cells from Peripheral Blood CD34+ Progenitor Cells
Therapeutic Approaches: Cytokines and Vaccines
Interleukin-12: Biology and Clinical Studies
Peptide Vaccines in Melanoma Patients
Ras Peptide Vaccines
Idiotype-Based Immunotherapy of Cancers
Heat-Shock-Protein-Based Vaccines against Cancers and Intracellular Infections.